Compare Abeona Therapeutics Inc (ABEO) vs Mercadolibre Inc (MELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Mercadolibre Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Mercadolibre Inc trades at $1,927.01 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 233.5× Abeona Therapeutics Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Abeona Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | MELI | |
|---|---|---|
Market Cap | $421.19M | $98.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $2.51K |
52-Week Low | $4.17 | $1.55K |
Enterprise Value | $276.10M | $106.00B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →
